Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProQR Therapeutics NV

1.35
+0.03002.27%
Volume:307.79K
Turnover:417.12K
Market Cap:142.04M
PE:-4.04
High:1.40
Open:1.35
Low:1.31
Close:1.32
Loading ...

ProQR Therapeutics to Receive $8.1 Million Funding from Rett Syndrome Research

MT Newswires Live
·
11 Dec 2024

ProQR Therapeutics announces $8.1M in new funding from RSRT

TIPRANKS
·
11 Dec 2024

ProQR Therapeutics Announces $8.1 Million in New Funding From Rett Syndrome Research Trust to Expand Rna Editing Collaboration

THOMSON REUTERS
·
11 Dec 2024

ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration

GlobeNewswire
·
11 Dec 2024

ProQR Therapeutics appoints Beal as Chief ADAR Scientist

TIPRANKS
·
10 Dec 2024

ProQR Highlights RNA Innovations in Upcoming Event

TIPRANKS
·
05 Dec 2024

ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

ProQR Therapeutics sees cash runway into mid-2027

TipRanks
·
08 Nov 2024

ProQR Therapeutics N.v. : H.c. Wainwright Raises Target Price to $10 From $5

THOMSON REUTERS
·
08 Nov 2024

ProQR Therapeutics Nv : Chardan Capital Markets Raises Target Price to $4 From $2.50

THOMSON REUTERS
·
08 Nov 2024

ProQR Announces Third Quarter 2024 Operating and Financial Results

THOMSON REUTERS
·
07 Nov 2024

ProQR Announces Third Quarter 2024 Operating and Financial Results

GlobeNewswire
·
07 Nov 2024

ProQR Therapeutics Raised to Strong Buy From Outperform by Raymond James

Dow Jones
·
29 Oct 2024

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

THOMSON REUTERS
·
26 Oct 2024

ProQR Announces Major Share Offering Agreement

TIPRANKS
·
26 Oct 2024